Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

NHS National Generic Pharmaceuticals Wave 15b

NHS England

This public procurement record has 2 releases in its history.

Award

04 Aug 2025 at 15:23

Award Notice
Tender

17 Feb 2025 at 15:11

Tender Notice
Summary of the contracting process

The public procurement process summarised here concerns NHS England's initiative titled "NHS National Generic Pharmaceuticals Wave 15b". It falls within the pharmaceutical products industry (CPV: 33600000) and involves the procurement of goods. The procurement stage is at the completion of the tender, with relevant activities noted as award and contract, asserting its status as complete. NHS England, centrally located in Leeds, is the buying organisation coordinating this open procurement process under the CELEX legal basis. This framework agreement encompasses several regions across the UK, including Midlands, Southwest, London South, Northeast, and others, with the main framework periods starting from 1st October 2025. The tendering process involved open procedure methods, with significant framework and call-off periods allowing potential extensions up to 48 months.

This procurement opportunity offers broad prospects for both SMEs and larger enterprises within the pharmaceutical sector. By engaging with NHS England's extensive framework agreement, businesses can potentially secure stable, long-term contracts that foster growth and expansion within the healthcare supply chain. The framework allows suppliers, including small and medium-sized enterprises, to benefit from large-scale NHS contracts, as evidenced by numerous supplier awards to both SMEs and larger organisations. Businesses offering oral, non-parenteral, and hospital-only pharmaceutical products should find themselves well-suited to participate and thrive within this framework, contingent on eligibility and fulfilment of procurement requirements.

How relevant is this notice?

Notice Information

Notice Title

NHS National Generic Pharmaceuticals Wave 15b

Notice Description

NHS National Pharmaceuticals Generic Products - Wave 15b<br/>Offer reference number: CM/PHG/23/5698<br/>Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) for a period or periods up to a total of 48 months.<br/>Potential periods of call-offs under the framework agreement:<br/>CM/PHG/23/5698/01 - Orals (plus non-parenteral) Products<br/>CESW: (Midlands and Southwest): 1st October 2025 to 31st May 2027 (20 months)<br/>NWLN: (Northwest and London North): 1st October 2025 to 31st May 2027 (20 months)<br/>LSNE: (London South and Northeast): 1st October 2025 to 31st May 2027 (20 months)<br/><br/>CM/PHG/23/5698/02 - Hospital Only Products<br/>DCE (Midlands) & DSW (Southwest): 1st October 2025 to 30th September 2027 (24 months)<br/><br/>CM/PHG/23/5698/03 - Hospital Only (Housekeeping) Products<br/>DLS (London South) & DNE (Northeast): 1st October 2025 to 31st May 2026 (8 months)<br/>DNW (Northwest) & DLN (London North): 1st October 2025 to 31st January 2027 (16 months)<br/>DCE (Midlands) & DSW (Southwest): 1st October 2025 to 31st May 2026 (8 months)

Lot Information

Lot 1 - CM/PHG/23/5698/01 - Orals (plus non-parenteral) Products all regions

Lot 1 CM/PHG/23/5698/01 - Orals (plus non-parenteral) Products
CESW: (Midlands and Southwest): 1st October 2025 to 31st May 2027 (20 months)
NWLN: (Northwest and London North): 1st October 2025 to 31st May 2027 (20 months)
LSNE: (London South and Northeast): 1st October 2025 to 31st May 2027 (20 months) Additional information: Price is not the only award criterion and all criteria are stated in the procurement documents

Options: Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months

Lot 2 - CM/PHG/23/5698/02 - Hospital Only products (DCE & DSW regions)

Lot 2: CM/PHG/23/5698/02 - Hospital Only Products
DCE (Midlands) & DSW (Southwest): 1st October 2025 to 30th September 2027 (24 months) Additional information: Price is not the only award criterion and all criteria are stated in the procurement documents

Options: Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months

Lot 3 - CM/PHG/23/5698/03 - Hospital Only (Housekeeping) Products

Lot 3: CM/PHG/23/5698/03 - Hospital Only (Housekeeping) Products
DLS (London South) & DNE (Northeast): 1st October 2025 to 31st May 2026 (8 months)
DNW (Northwest) & DLN (London North): 1st October 2025 to 31st January 2027 (16 months)
DCE (Midlands) & DSW (Southwest): 1st October 2025 to 31st May 2026 (8 months) Additional information: Price is not the only award criterion and all criteria are stated in the procurement documents

Options: Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-04e2d4
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/045712-2025
Current Stage
Award
All Stages
Tender, Award

Procurement Classification

Notice Type
Award Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
Not specified
Awardee Scale
Large, SME

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£742,316,345 £100M-£1B
Lots Value
£742,316,345 £100M-£1B
Awards Value
Not specified
Contracts Value
£1

Notice Dates

Publication Date
4 Aug 20251 years ago
Submission Deadline
24 Mar 2025Expired
Future Notice Date
Not specified
Award Date
Not specified
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Cancelled
Awards Status
Active
Contracts Status
Active

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
NHS England
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
LEEDS
Postcode
LS1 4AP
Postcode Area
Leeds
Country
England
Major Region (ITL 1)
TLE Yorkshire and The Humber
Basic Region (ITL 2)
TLE4 West Yorkshire
Small Region (ITL 3)
TLE42 Leeds
Delivery Location
Not specified
Local Authority
Leeds
Electoral Ward
Hunslet & Riverside
Westminster Constituency
Leeds South

Supplier Information

Number of Suppliers
103
Supplier Names

Pfizer Ltd

Alissa Healthcare Research Limited

Sandoz Ltd

Scope Ophthalmics

Milpharm Ltd/aurobinbdo Primary

MSN Laboratories Europe Limited

Biocon

Accord-UK Ltd

Medreich PLC

Morningside Pharmaeuticals

Thornton and Ross Ltd

Amarox Limited

Galen Ltd

Farmak Pharmaceuticals

Drugsrus Ltd

Dr.Reddy's Laboratories (UK) Limited

Brown & Burk UK Ltd

Otsuka Pharmaceuticals UK Limited

LogixX Pharma Ltd

Fresenius Kabi Limited

Hikma Pharmaceuticals

Merck Sharpe & Dohme (UK) Limited

Piramal Critical care Limited

Zentiva Pharma UK Ltd

Fontus Health Ltd

Colonis Pharma Ltd

Galvany Pharma Ltd

Essential Pharma

Mercury Pharmaceuticals Limited

Ascend Laboratories UK Ltd

Aguettant Ltd

GlaxoSmithKline UK Limited

Celix Pharma Ltd.

Neon Healthcare Ltd

GENNISIUM PHARMA

Baxter Healthcare Ltd

Lundbeck Limited

Macure Pharma ApS

Flexipharm Austrading Limited

Kent Pharma Ltd

medac Pharma LLP

Novumgen Limited

Bowmed Ibisqus Limited

Aspen Pharmacare UK Limited

Mylan

Teva UK Limited

Perennial Pharma Ltd

B. Braun Medical Limited

FLYNN PHARMA LTD

Consilient Health Ltd

AGB Pharma

Aventis Pharma ltd

Seacross Pharmaceuticals Ltd

Intrapharm Laboratories Ltd

Ranbaxy (UK) Ltd

Martindale Pharma

Selective Supplies Ltd

G.L. Pharma UK Limited

Chiesi Limited

Aspire Pharma Ltd

Reig Jofre UK limited

Wockhardt UK Limited

Strides Pharma Uk LTD

Arcadia Pharma Ltd

Manx Healthcare Ltd

Pierre Fabre Ltd

JCSH Pharma Ltd

Tillomed Laboratories ltd

Glenmark Pharmaceuticals Europe Ltd

Desitin Pharma Ltd

Ennogen Healthcare Ltd

Roche Products Ltd

AOP Orphan Ltd

Ferring Pharmaceuticals Ltd

Immedica Pharma AB

PARI Medical Ltd

Day Lewis Medical Ltd

CST Pharma Limited

Neuraxpharm UK Ltd

Thea Pharmaceuticals Limited

Sobi (Swedish Orphan Biovitrum Ltd)

hameln pharma ltd

Panpharma UK Limited

Lipomed AG

Phoenix Lab

Torbay Pharmaceuticals

Vantage Pharmaceuticals Ltd

Eramol (UK) Ltd

Crescent Pharma Limited

Recordati Pharmaceuticals Ltd

Macleods Pharma UK Limited

Waymade PLC

Roma Pharmaceuticals Limited

Synchrony

Necessity Supplies Limited

Torrent Pharma UK Ltd

Focus Pharmaceuticals Ltd

Cipla

Lucane Pharma

Stirling Anglian Pharmaceuticals Ltd

RPH Pharmaceuticals AB

Beaumont Pharma Ltd

SVP Pharma Ltd

Further Information

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...